PGLA-based Nanoparticles 4ml

The University of Nebraska Medical Center, a state agency operating under the Board of Regents of the University of Nebraska, awarded a purchase order valued at $4,720.00 to Mountview Therapeutics LLC, an Illinois-based vendor. The contract, issued on February 11, 2026, with reference number 4800178473, calls for the delivery of one unit of Poly(D,L-lactide-co-glycolide) (PGLA)-based Nanoparticles in a 4-milliliter quantity at a unit price of $4,720.00. The material is identified by vendor material number 1033 and is subject to the University of Nebraska's Standard Terms of Purchase.

Performance of this purchase order is scheduled for completion by February 16, 2026, with delivery required to the UNMC facility located at 601 South Saddle Creek Road, Omaha, Nebraska. The contract terms specify Net 30 payment terms, F.O.B. Destination shipping basis with freight prepaid by the vendor, and vendor acknowledgment of acceptance required within ten days. Zhenguo Liu is designated as the unloading point contact at the delivery location. All invoices and related documentation must reference purchase order number 4800178473 to facilitate prompt payment processing.